In situ and invasive components of mammary adenocarcinoma: Comparison of Her-2/neu status

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 4, 2007, Pages 239-243

  Layfield, Lester J ^a,b   Lewis, Cameron ^a  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma, in situ; Carcinoma, invasive; Her 2 neu

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB;

ARTICLE; BREAST ADENOCARCINOMA; CANCER INVASION; CARCINOMA IN SITU; GENE AMPLIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TREATMENT RESPONSE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548158924     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Van De Vijver MJ, Peterge JL, Nooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R: Neu protein over-expression in breast cancer: Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 1988;319:1239-1245
2. Liu E, Thor A, Barcos M, Ljung B-M, Benz C: The Her-2 (c-erb B-2) oncogene is frequently amplified in in-situ carcinomas of the breast. Oncogene 1992;7:1027-1032
3. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL: Overexpression of Her-2/neu and its relationship with other prognostic factors change during the progression of in-situ to invasive breast cancer. Hum Pathol 1992;23:974-979
4. Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM: Her-2/neu amplification in ductal carcinoma in-situ of the breast. Cancer Epidemiol Biol Prev 2002;11:587-590
5. Pavelic ZP, Pavelic L, Lowe EE, Gapany M, Gapany S, Barker EA, Preisler HD: C-myc, c-erb B-2 and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer Res 1992;52:2597-2602
6. Schimmelpenning H, Eriksson ET, Falkmer UG, Azavedo E, Svane G, Auer GU: Expression of the c-erb B-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma. Virchow Arch A, Pathol Anat Histopathol 1992;420:433-440
7. Iglehart JD, Kerns B-J, Huper G, Marks JR: Maintenance of DNA content and erb B-2 alterations in intraductal and invasive phases of mammary cancer. Breast Cancer Res Treat 1995;34:253-263
8. Somerville JE, Clarke LA, Biggart JD: C-erb B-2 over expression and histologies (type of in-situ and invasive breast cancer). J Clin Pathol 1992;45:16-20
9. Hoff ER, Tubbs RR, Myles JL, Procop GW: Her-2/neu amplification in breast cancer: Stratification by tumor type and grade. Am J Clin Pathol 2002;117:916-921